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Abstract
Few studies in the literature have looked into the cardiovascular and metabolic effects of Obstruc-
tive Sleep Apnea Syndrome (OSAS) in children.
Objective: This study aims to evaluate the metabolic profile of non-obese children with OSAS.
Methods: Fifty-two children were enrolled in this study, 21 girls and 31 boys. Patients were divided 
into two groups: OSAS (28 children) and Snore (22 children) according to polysomnographic evalu-
ation. All children were submitted to ENT examination, measurements of weight, height and blood 
pressure. Blood samples were tested for hemoglobin, hematocrit, fasting glucose, fasting insulin, 
triglycerides, total cholesterol, HDL, LDL, VLDL, TSH and T4. The gathered data sets were compared 
between groups and also within the OSAS group according to the severity of the syndrome.
Results: The children from both groups had no alterations in blood pressure levels. The results of 
the blood tests were normal for both groups. Results of hemoglobin, hematocrit, and HDL were 
all significantly higher in the Snore group when compared to the OSAS group; by their turn, VLDL 
levels were higher in the OSAS group. There was no statistical difference between the groups based 
on OSAS severity.
Conclusion: Non-obese children with OSAS present no significant alterations in metabolic tests or 
blood pressure levels.
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INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a 
respiratory sleep disorder that affects adults and children. 
It is characterized by repeated episodes of upper airway 
obstruction accompanied by intermittent hypoxia and hy-
percapnia1.
Prevalence rates reported in the literature range be-
tween 0.7% and 3%. Incidence rates peak among preschool-
ers, as this age group is more affected by adenotonsillar 
hypertrophy, the main cause of OSAS in children1. The 
treatment of pediatric OSAS is adenotonsillectomy or, in 
rare cases, CPAP1-3.
OSAS may have severe clinical consequences such 
as cor pulmonale, in addition to other cardiovascular and 
metabolic disorders, delays in weight and height gain, facial 
and chest skeletal alterations, nocturnal enuresis, behavior 
and learning disorders, and cognitive impairments1,4.
The association between OSAS and systemic high 
blood pressure and other cardiovascular and metabolic 
diseases has been well documented1,5-8. Sleep disorders and 
intermittent nocturnal hypoxemia in combination with OSAS 
have been related to metabolic disorders including altered 
glucose metabolism and dyslipidemia. Evidence suggests 
an association between OSAS and diabetes mellitus type 2, 
glucose intolerance, and insulin resistance9.
Studies in pediatric populations have shown an as-
sociation between OSAS and alterations in systemic blood 
pressure levels10,11, echocardiographic findings12,13 and 
insulin resistance14,15. These alterations seem to be present 
mainly in children with moderate to severe OSAS and in 
obese kids16. Only a few studies have looked into the con-
sequences of OSAS in non-obese children.
This study compared the clinical profiles of non-
-obese children with OSAS and primary snoring.
METHOD
The study was approved by the Research Ethics Com-
mittee of the institution and granted permit CEP 1814/08. 
Pediatric patients seen in an outpatient setting between 
March of 2009 and August of 2010 were enrolled. The 
subjects were aged between three and 13 years and were 
predominantly mouth breathers. They had been snoring 
three or more days per week for at least six months and 
had a body mass index (BMI) equal to or under the 95th 
percentile based on age and gender. Obese and diabetic 
subjects and individuals with cardiovascular, metabolic or 
neuromuscular diseases, genetic syndromes or craniofacial 
malformations were excluded.
The patients underwent complete ENT examination 
and had their weight, height, and blood pressure (BP) me-
asured . BP was measured with the patients seated after 
resting for at least 20 minutes. A proper cuff for the patients’ 
age and weight was used. BP measurements were categori-
zed as ‘altered’ or ‘unaltered’ in accordance with the second 
release of the table published by the National Task Force 
on Hypertension of the National Heart, Lung and Blood 
Institute endorsed by the American Academy of Pediatrics 
in 1987 and reviewed in 199617,18. Systolic or diastolic BP 
values under the 90th percentile were considered normal.
Tonsillar hypertrophy was categorized in four de-
grees as per the scheme proposed by Brodsky19, while 
pharyngeal tonsil hypertrophy was assessed through na-
sopharyngeal endoscopic examination. Grades III and IV 
were considered as obstructive palatine tonsil hypertrophy. 
Obstruction caused by the pharyngeal tonsil was charac-
terized when it occupied 70% or more of the cavum area.
All subjects underwent polysomnography. Obstruc-
tive apnea was characterized as the presence of inspiratory 
effort in the absence of airflow for at least two respiratory 
events. Hypopnea was defined as a reduction of at least 
50% in airflow amplitude in the presence of inspiratory 
effort and oxyhemoglobin desaturation of at least 4%, or 
the subject awakening. The apnea hypopnea index (AHI) 
was defined as the set of obstructive and mixed (central 
and obstructive components) apnea and hypopnea episodes 
per hour of sleep20. OSAS was defined as the presence of 
AHI ≥ 1. If AHI ≥ 1 and < 5, the patient had mild OSAS; if 
AHI ≥ 5 and < 10, the subject had moderate OSAS; severe 
cases had AHI ≥ 10.
Fasting blood samples were taken to assess hemo-
globin (Hb), hematocrit (Ht), fasting glucose, fasting insu-
lin, triglycerides, total cholesterol and cholesterol fractions 
(HDL, LDL, VLDL), TSH and free T4 levels.
Non-parametric tests were used in this study.
The test for equality of two proportions was used 
to compare whether the proportions of responses of two 
variables and/or their levels are statistically significant. The 
Mann-Whitney test was used to compare variables from 
independent samples two by two. The Kruskal-Wallis test 
was used to compare the three degrees of OSAS severity 
to all quantitative variables.
Spearman’s rank correlation ratio was used to me-
asure the correlation between all variables and the OSAS 
degree of severity. The correlation test was used to validate 
the correlations.
Significance was set at 0.05 (5%). All confidence inter-
vals used in this study had a 95% statistical confidence level.
RESULTS
Fifty-two children were enrolled in the study, 21 
(40.38%) of them being girls and 31 (59.61%) boys. The 
patients were divided into two groups: OSAS (AHI ≥ 1 
event per hour) and Snoring (AHI < 1 event per hour). 
Both groups were homogeneous in terms of gender and 
age. Twenty-eight children were included in the Snoring 
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Group (13 females and 15 males), while the OSAS Group 
had 24 subjects (8 females and 16 males). In the OSAS 
Group, eleven children had mild OSAS, seven had moderate 
OSAS, and six had severe OSAS. Mean ages were 8.07 years 
in the Snoring Group and 6.67 years in the OSAS Group.
All subjects had obstructive OSAS caused by hyper-
trophied lymphoid tissue. In the OSAS Group, 18 (75%) 
children had hypertrophied pharyngeal tonsils and 15 
(62.5%) had hypertrophied tonsils. In the Snoring Group, 
13 (46.4%) individuals had hypertrophied pharyngeal tonsils 
and 10 (35.7%) had hypertrophied tonsils.
The subjects from both groups had unaltered BP 
levels.
The groups were compared for quantitative variables 
age, BMI, Hb, Ht, fasting glucose, total cholesterol, cho-
lesterol fractions, triglycerides, insulin, TSH, an free T4 as 
described on Table 1.
Table 1. Analysis of quantitative variables in Snoring and OSAS 
Groups.
OSAS: obstructive sleep apnea syndrome; n: number of subjects; 
BMI: body mass index; Hb: Hemoglobin; Ht: Hematocrit; HDL: high 
density lipoprotein; LDL: low density lipoprotein; VLDL: very low den-
sity lipoprotein; TSH: thyroid-stimulating hormone; free T4: thyroxine.
Snoring OSAS p
Age (years) 8.07 ± 2.75 6.67 ± 3.48 0.084
BMI (Kg/cm2) 16.91 ± 3.23 17.23 ± 4.37 0.653
Hb (g/dL) 13.41 ± 0.88 12.69 ± 0.80 0.004
Ht (%) 39.78 ± 2.24 38.15 ± 2.59 0.024
Glucose (mg/dL) 87.04 ± 6.17 85.29 ± 7.93 0.382
Cholesterol (mg/dL) 147.07 ± 22.62 149.38 ± 25.36 0.666
HDL (mg/dL) 49.39 ± 6.05 44.79 ± 7.05 0.009
LDL (mg/dL) 84.85 ± 20.38 86.76 ± 20.60 0.707
VLDL (mg/dL) 12.65 ± 4.71 17.83 ± 12.81 0.049
Triglycerides (mg/dL) 65.04 ± 23.68 89.17 ± 64.13 0.097
Insulin (µUI/mL) 3.48 ± 2.34 2.84 ± 2.41 0.142
TSH (µUI/mL) 2.16 ± 1.17 2.29 ± 0.84 0.409
Free T4 (ng/dL) 0.94 ± 0.11 1.33 ± 1.79 0.308
The studied variables had normal values in both 
groups. However, statistically significant differences were 
found between the groups for Hb, Ht, HDL, and VLDL. 
Among these, only VLDL was higher in the OSAS Group 
than in the Snoring Group.
The subjects in the OSAS Group were analyzed to 
compare the three degrees of syndrome severity and their 
quantitative variables. The differences observed between 
the subjects with various degrees of OSAS severity were 
not statistically significant.
The possible correlations between all variables 
and OSAS severity were analyzed for the OSAS Group 
(Table 2).
Table 2. Correlation between variables and OSAS severity
Correlation p-value
Age (years) 3.60% 0.866
Hb (g/dL) 13.20% 0.538
Ht (%) 2.10% 0.922
Glucose (mg/dL) -36.50% 0.079
Cholesterol (mg/dL) -4.20% 0.844
HDL (mg/dL) 7.80% 0.717
LDL (mg/dL) -2.60% 0.904
VLDL (mg/dL) 4.80% 0.822
Triglycerides (mg/dL) 4.80% 0.822
Insulin (µUI/mL) -46.60% 0.022
TSH (µUI/mL) -11.80% 0.582
Free T4 (ng/dL) 40.50% 0.049
OSAS: obstructive sleep apnea syndrome; Hb: Hemoglobin; Ht: He-
matocrit; HDL: high density lipoprotein; LDL: low density lipoprotein; 
VLDL: very low density lipoprotein; TSH: thyroid-stimulating 
hormone; free T4: thyroxine.
There was a negative correlation between 
the degree of severity and insulin (-46.6%) and a positive 
one with free T4 (40,5%). Both correlations were rated 
as Fair.
DISCUSSION
Many papers in the literature have shown that 
children with OSAS have altered BP levels10,21,22. 
Altered BP levels were not observed in this study for the 
non-obese children of either of the groups. Kaditis et al.16 
also failed to show altered BP levels in non-obese children 
with OSAS, but we found significantly higher BP values 
in the OSAS Group when compared to subjects in the 
control group. The study done by Amin et al.12 in 2002 
did not reveal altered BP levels in children with OSAS or 
in primary snorers.
The metabolic indices of the patients in both 
groups were not altered. Only VLDL was increased and 
HDL cholesterol was significantly lower in children with 
OSAS. Hemoglobin and hematocrit levels were signifi-
cantly higher in the patients without OSAS. Kaditis et al.16 
studied non-obese children with OSAS and did not find 
differences in total cholesterol, cholesterol fractions, tri-
glycerides, and insulin levels when compared to children 
without OSAS.
Only patients with OSAS were checked to see 
whether there was any variation in their metabolic indi-
ces in association with OSAS severity, but no statistically 
significant differences were found between OSAS severity 
and the analyzed metabolic indices. It was observed that 
increasing degrees of disease severity led to lower insulin 
levels and higher free T4 values.
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These results vary from the ones reported by de la 
Eva et al.14, in which a positive correlation was established 
between OSAS severity and insulin levels in children re-
gardless of BMI. In China, obese children with OSAS were 
studied, and increased levels of insulin were found in 
this group, in a positive correlation with OSAS severity23. 
Redline et al.10 studied a group of teens and showed that 
adolescents with sleep respiratory disorders have seven 
times more chance of having metabolic alterations than 
adolescents with no sleep disorders. After adjustments for 
gender and BMI, these adolescents had higher levels of 
BP, insulin, and LDL cholesterol.
Nonetheless, the study conducted by Tauman et 
al.24 verified that obesity, and not OSAS, is the determining 
factor for insulin resistance and metabolic alterations seen 
in their cohorts. This study can explain why our study and 
in the one by Kaditis no metabolic alterations were found 
in non-obese children with and without OSAS. It appears 
that fat tissue plays an important role as a mediator for 
cytokines, growth factors, and sex steroids, which alter 
the action and secretion of insulin25.
A longitudinal study done with children showed 
that metabolic alterations are more evident between 
10 and 19 years of age26. The differing results seen in the 
studies mentioned above may be related to the variations in 
age of the studied populations. Positive findings may prevail 
in older children and in adolescents, as they have been en-
during the consequences of OSAS for longer than younger 
subjects, not to mention the impact of puberal changes.
Another confounding factor in OSAS pediatric 
studies is obesity, which in some papers is reported as 
a determining factor for the presence of metabolic alte-
rations while not in others. More studies are required to 
look into children with OSAS and metabolic alterations by 
separating obese from non-obese subjects and analyzing 
them by age range.
Our study looked only at non-obese children to 
isolate the consequences associated with OSAS from obe-
sity. Age is known to affect the onset of metabolic altera-
tions. Therefore, it is important to divide subjects based 
on their ages. However, given the difficulties inherent to 
polysomnographic examination, our sample had a limited 
number of subjects and could not be further divided into 
age-based subgroups.
The literature on adult OSAS is extensive, but few 
studies have been carried out on pediatric sleep respiratory 
disorders. The papers on children with OSAS and meta-
bolic and inflammatory disorders have diverging results, 
mainly because of the myriad of methods employed to 
categorize OSAS and the variations in the data related to 
subject age. Adolescents appear to have different metabolic 
characteristics than younger children, but they have been 
studied together in most papers, which have thus failed 
to recognize the age-related variations.
CONCLUSION
Non-obese children with OSAS did not present 
significant blood pressure or metabolic alterations when 
compared to pediatric primary snoring patients.
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